730 related articles for article (PubMed ID: 18677725)
1. Effects of the German reference drug program on ex-factory prices of prescription drugs: a panel data approach.
Augurzky B; Göhlmann S; Gress S; Wasem J
Health Econ; 2009 Apr; 18(4):421-36. PubMed ID: 18677725
[TBL] [Abstract][Full Text] [Related]
2. [Pharmaceutical reference pricing in Germany: definition of therapeutic groups, price setting through regression procedure and effects].
Stargardt T; Schreyögg J; Busse R
Gesundheitswesen; 2005 Jul; 67(7):468-77. PubMed ID: 16103970
[TBL] [Abstract][Full Text] [Related]
3. Do pharmaceutical prices respond to potential patient out-of-pocket expenses?
Pavenik N
Rand J Econ; 2002; 33(3):469-87. PubMed ID: 12585303
[TBL] [Abstract][Full Text] [Related]
4. Competition and the Reference Pricing Scheme for pharmaceuticals.
Ghislandi S
J Health Econ; 2011 Dec; 30(6):1137-49. PubMed ID: 21937137
[TBL] [Abstract][Full Text] [Related]
5. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
6. Trends in manufacturer prices of brand name prescription drugs used by older Americans--first quarter 2004 update.
Gross DJ; Schondelmeyer SW; Raetzman SO
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2004 Jun; (IB69):1-12, 1-2. PubMed ID: 15368653
[TBL] [Abstract][Full Text] [Related]
7. Price regulation and generic competition in the pharmaceutical market.
Dalen DM; Strøm S; Haabeth T
Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230
[TBL] [Abstract][Full Text] [Related]
8. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
Openshaw MS
Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
[TBL] [Abstract][Full Text] [Related]
9. [International reference prices and cost minimization analysis for the regulation of medicine prices in Colombia].
Vacca C; Acosta A; Rodriguez I
Value Health; 2011; 14(5 Suppl 1):S16-9. PubMed ID: 21839891
[TBL] [Abstract][Full Text] [Related]
10. Points to consider about prescription drug prices: an overview of federal policy and pricing studies.
Kucukarslan S; Hakim Z; Sullivan D; Taylor S; Grauer D; Haugtvedt C; Zgarrick D
Clin Ther; 1993; 15(4):726-38. PubMed ID: 8221823
[TBL] [Abstract][Full Text] [Related]
11. Examining the production costs of antiretroviral drugs.
Pinheiro E; Vasan A; Kim JY; Lee E; Guimier JM; Perriens J
AIDS; 2006 Aug; 20(13):1745-52. PubMed ID: 16931939
[TBL] [Abstract][Full Text] [Related]
12. Pricing behaviour of pharmacies after market deregulation for OTC drugs: the case of Germany.
Stargardt T; Schreyögg J; Busse R
Health Policy; 2007 Nov; 84(1):30-8. PubMed ID: 17553587
[TBL] [Abstract][Full Text] [Related]
13. [Current problems in assessing drug prices].
Lucioni C
Medicina (Firenze); 1989; 9(4):429-36. PubMed ID: 2634234
[TBL] [Abstract][Full Text] [Related]
14. [Risk sharing methods in middle income countries].
Inotai A; Kaló Z
Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
[TBL] [Abstract][Full Text] [Related]
15. Reference pricing and firms' pricing strategies.
Miraldo M
J Health Econ; 2009 Jan; 28(1):176-97. PubMed ID: 19038465
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical promotion and GP prescription behaviour.
Windmeijer F; de Laat E; Douven R; Mot E
Health Econ; 2006 Jan; 15(1):5-18. PubMed ID: 15945041
[TBL] [Abstract][Full Text] [Related]
17. Competitive pricing within pharmaceutical classes: evidence on "follow-on" drugs in Germany 1993-2008.
Mueller MT; Frenzel A
Eur J Health Econ; 2015 Jan; 16(1):73-82. PubMed ID: 24370790
[TBL] [Abstract][Full Text] [Related]
18. Impact of European pharmaceutical price regulation on generic price competition: a review.
Puig-Junoy J
Pharmacoeconomics; 2010; 28(8):649-63. PubMed ID: 20515079
[TBL] [Abstract][Full Text] [Related]
19. Examining the link between price regulation and pharmaceutical R&D investment.
Vernon JA
Health Econ; 2005 Jan; 14(1):1-16. PubMed ID: 15386673
[TBL] [Abstract][Full Text] [Related]
20. Elasticities of market shares and social health insurance choice in Germany: a dynamic panel data approach.
Tamm M; Tauchmann H; Wasem J; Gress S
Health Econ; 2007 Mar; 16(3):243-56. PubMed ID: 16981190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]